
Applying Individualized Therapeutic Strategies of Switching and Sequencing to Improve Outcomes for Patients With Multiple Sclerosis
This content is derived from a CME symposium held in conjunction with the Advanced Curriculum for Multiple Sclerosis 2018 in San Diego, California. The five expert faculty will highlight individualized therapeutic strategies of switching and sequencing to improve outcomes for patients with multiple sclerosis (MS). Methods for predicating and monitoring disease therapy in the MS patient population will be reviewed ...
View Course
View Course

Novel Therapeutics in the Treatment and Management of Multiple Myeloma at ASH 2017
This CME/CNE program will discuss recent advances in the treatment and management of multiple myeloma (MM) as presented at the American Society of Hematology 59th Annual Meeting & Exposition in Atlanta, Georgia. The expert faculty panel will provide learners with a scientific update regarding kidney toxicity, fractures, and other skeletal related events as they relate to MM patient care. Recent ...
View Course
View Course

Clinical Updates on Disease Modifying Therapies to Improve Outcomes for Patients with Multiple Sclerosis
This educational activity will feature content presented at the MS Paris 2017 7th Joint ECTRIMS-ACTRIMS Meeting in Paris, France. Four expert faculty will examine recent prognosis and diagnostic strategies of multiple sclerosis. An analysis of clinical trial data of current and emerging disease modifying therapies as presented at the Joint ACTRIMS-ECTRIMS meeting will be discussed. The faculty will also review ...
View Course
View Course

Best Practices to Apply JAK Inhibitors for the Management of Patients With Polycythemia Vera
This CE program will highlight recent scientific advances in the treatment and management of patients with polycythemia vera (PV) presented at the American Society of Hematology 59th Annual Meeting & Exposition in Atlanta, Georgia. The three expert faculty will review the science and diagnostic criteria of PV, focusing on the treatment of the resistant/intolerant patient population. Recent clinical trial data, ...
View Course
View Course

Clinical Trial Update: Therapeutic Strategies to Delay Disease Progression
In this module of a Four-Part Expert Interview Series, Dr. Marc E. Agronin, along with Dr. Richard S. Isaacson, course chair, will evaluate available therapeutic options for Alzheimer’s disease (AD) patient. The faculty will highlight the evolution of failed and existing therapies in AD, and their impact on current clinical care, emphasizing strategies for delaying disease progression in the modern ...
View Course
View Course

Early Diagnosis and Disease Monitoring: Pathology and Biomarkers
In this module of a Four-Part Expert Interview Series, Dr. James E. Galvin, along with Dr. Richard S. Isaacson, course chair, will relay optimal strategies for early diagnosis of Alzheimer’s disease (AD). Signs and symptoms for the mild, moderate and severe forms of AD will be analyzed, as well as modifiable and non-modifiable risk factors. The faculty will also review ...
View Course
View Course

Non-Pharmacological Approaches to Managing Patients With Alzheimer’s Disease
In this module of a Four-Part Expert Interview Series, Max Lugavere, along with Dr. Richard S. Isaacson, course chair, will explore non-pharmacological approaches to managing patients with Alzheimer’s disease (AD). Multi-modal intervention factors, including nutrition exercise, sleep hygiene and continued education, among others, will be reviewed, and best practices relayed. The faculty will also highlight recent clinical trial data regarding ...
View Course
View Course